Approaches to disease progression modelling for identifying predictors of future cognitive decline in dementia

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Reader response: Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

  2018cited by this paper
• Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod

  2018cited by this paper
• Type 2 diabetes, depressive symptoms and trajectories of cognitive decline in a national sample of community-dwellers: A prospective cohort study

  2017cited by this paper
• Informative Observation in Health Data: Association of Past Level and Trend with Time to Next Measurement.

  2017influential reference
• Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons

  2017cited by this paper
• Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: modelling study

  2017influential reference
• Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice

  2017cited by this paper
• Plasma neurofilament light chain levels in Alzheimer's disease.

  2017cited by this paper
• Bayesian analysis of genetic association across tree-structured routine healthcare data in the UK Biobank

  2017cited by this paper
• Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

  2017cited by this paper
• Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort

  2017cited by this paper
• Trajectories of decline in cognition and daily functioning in preclinical dementia

  2016cited by this paper
• Post-mortem assessment in vascular dementia: advances and aspirations

  2016cited by this paper
• The Prevalence and Incidence of Dementia with Lewy Bodies: a Systematic Review

  2016cited by this paper
• The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study

  2016cited by this paper
• Analysing cognitive test data: Distributions and non-parametric random effects

  2016cited by this paper
• Characterizing treatment pathways at scale using the OHDSI network

  2016cited by this paper
• Brain fluorodeoxyglucose (FDG) PET in dementia.

  2016cited by this paper
• Occupational cognitive requirements and late-life cognitive aging

  2016cited by this paper
• Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease

  2016cited by this paper
• NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers.

  2016cited by this paper
• Genes associated with Alzheimer’s disease: an overview and current status

  2016cited by this paper
• Cohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: current status and recent enhancement of an Electronic Mental Health Record-derived data resource

  2016cited by this paper
• High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer’s disease

  2016cited by this paper
• SIMR: an R package for power analysis of generalized linear mixed models by simulation

  2016cited by this paper
• Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.

  2016cited by this paper
• Impact of smoking on neurodegeneration and cerebrovascular disease markers in cognitively normal men

  2016cited by this paper
• Neurofilament light chain: a biomarker for genetic frontotemporal dementia

  2016cited by this paper
• Effectiveness of Fluticasone Furoate-Vilanterol for COPD in Clinical Practice.

  2016cited by this paper
• Anxiety as a Predictor for Cognitive Decline and Dementia: A Systematic Review and Meta-Analysis.

  2016cited by this paper
• Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations.

  2016cited by this paper
• Association of genetic risk factors with cognitive decline: the PATH through life project.

  2016cited by this paper
• Incidence of Dementia over Three Decades in the Framingham Heart Study.

  2016cited by this paper
• Association of Higher Cortical Amyloid Burden With Loneliness in Cognitively Normal Older Adults.

  2016cited by this paper
• Diabetes mellitus Type II and cognitive capacity in healthy aging, mild cognitive impairment and Alzheimer's disease.

  2016cited by this paper
• Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study

  2016cited by this paper
• Longitudinal associations between late-life depression dimensions and cognitive functioning: a cross-domain latent growth curve analysis

  2016cited by this paper
• Association between Antipsychotic Drugs and Mortality in Older Persons with Alzheimer’s Disease: A Systematic Review and Meta-Analysis

  2016cited by this paper
• Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment

  2016cited by this paper
• Polygenic risk of Alzheimer disease is associated with early- and late-life processes

  2016cited by this paper
• A multivariate finite mixture latent trajectory model with application to dementia studies

  2016cited by this paper
• Mood instability is a common feature of mental health disorders and is associated with poor clinical outcomes

  2015cited by this paper
• World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends

  2015influential reference
• Effect of APOE and CD33 on Cognitive Decline

  2015cited by this paper
• A Linear Mixed Model Spline Framework for Analysing Time Course ‘Omics’ Data

  2015cited by this paper
• Age-Stratified Prevalence of Mild Cognitive Impairment and Dementia in European Populations: A Systematic Review

  2015cited by this paper
• Identification of Adverse Drug Events from Free Text Electronic Patient Records and Information in a Large Mental Health Case Register

  2015cited by this paper
• Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process

  2015cited by this paper
• Heritability of Cognitive Traits Among Siblings with a Parental History of Alzheimer's Disease

  2015cited by this paper
• Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease.

  2015cited by this paper
• The mix matters: complex personal networks relate to higher cognitive functioning in old age.

  2015cited by this paper
• Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study

  2015cited by this paper
• A 9-Week Aerobic and Strength Training Program Improves Cognitive and Motor Function in Patients with Dementia: A Randomized, Controlled Trial.

  2015cited by this paper
• Eliminating Bias in Classify-Analyze Approaches for Latent Class Analysis

  2015cited by this paper
• Effects of education and race on cognitive decline: An integrative study of generalizability versus study-specific results.

  2015cited by this paper
• Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.

  2015cited by this paper
• Depression, Vascular Factors, and Risk of Dementia in Primary Care: A Retrospective Cohort Study

  2015cited by this paper
• Longitudinal relationships between Alzheimer disease progression and psychosis, depressed mood, and agitation/aggression.

  2015influential reference
• Cigarette smoking and thinning of the brain's cortex

  2015cited by this paper
• Latent classes of course in Alzheimer's disease and predictors: the Cache County Dementia Progression Study

  2015cited by this paper
• Blood protein predictors of brain amyloid for enrichment in clinical trials?

  2015influential reference
• Antidepressant Use and Cognitive Decline: The Health and Retirement Study.

  2015cited by this paper
• A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease

  2014cited by this paper
• A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival

  2014cited by this paper
• Clinical-pathologic study of depressive symptoms and cognitive decline in old age

  2014cited by this paper
• Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients

  2014cited by this paper
• A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing

  2014cited by this paper
• Mini-Mental State Examination as a Predictor of Mortality among Older People Referred to Secondary Mental Healthcare

  2014cited by this paper
• Plasma proteins predict conversion to dementia from prodromal disease

  2014cited by this paper
• Change in leisure and social activities and risk of dementia in elderly cohort

  2014influential reference
• Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions.

  2014cited by this paper
• Anxiety is not associated with the risk of dementia or cognitive decline: the Rotterdam Study.

  2014cited by this paper
• Cognitive decline after entering a nursing home: a 22-year follow-up study of institutionalized and noninstitutionalized elderly people.

  2014cited by this paper
• Age-Related Incidence and Family History in Frontotemporal Dementia: Data from the Swedish Dementia Registry

  2014cited by this paper
• Factors Associated with Response to Acetylcholinesterase Inhibition in Dementia: A Cohort Study from a Secondary Mental Health Care Case Register in London

  2014influential reference
• Prescription of antipsychotics in people with dementia.

  2014cited by this paper
• Evaluation of two-fold fully conditional specification multiple imputation for longitudinal electronic health record data

  2014cited by this paper
• Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.

  2014cited by this paper
• Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.

  2014cited by this paper
• Associations between risk of mortality and atypical antipsychotic use in vascular dementia: a clinical cohort study

  2014cited by this paper
• An introduction to latent variable mixture modeling (part 2): longitudinal latent class growth analysis and growth mixture models.

  2014cited by this paper
• Genome‐wide association study of the rate of cognitive decline in Alzheimer's disease

  2014influential reference
• Mental work demands, retirement, and longitudinal trajectories of cognitive functioning.

  2014cited by this paper
• Polygenic Risk for Alzheimer's Disease is not Associated with Cognitive Ability or Cognitive Aging in Non-Demented Older People

  2014influential reference
• The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.

  2014influential reference
• The Associations between Serum Brain-Derived Neurotrophic Factor, Potential Confounders, and Cognitive Decline: A Longitudinal Study

  2014cited by this paper
• The Effect of Clozapine on Premature Mortality: An Assessment of Clinical Monitoring and Other Potential Confounders

  2014cited by this paper
• Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology

  2014cited by this paper
• Comparative mortality risks of antipsychotic medications in community-dwelling older adults.

  2014cited by this paper
• Obtaining real-world evidence: the Salford Lung Study

  2014cited by this paper
• Linear Quantile Mixed Models: The lqmm Package for Laplace Quantile Regression

  2014cited by this paper
• A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study

  2014cited by this paper
• Disease progression subtype discovery from longitudinal EMR data with a majority of missing values and unknown initial time points

  2014cited by this paper
• Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

  2014cited by this paper
• Mild Cognitive Impairment: Diagnosis, Longitudinal Course, and Emerging Treatments

  2014influential reference
• Nonlinear longitudinal trajectories of cholesterol and neuropsychological function.

  2014cited by this paper
• Longitudinal cognitive decline in the AIBL cohort: The role of APOE ε4 status.

  2014cited by this paper
• Genetic susceptibility to accelerated cognitive decline in the US Health and Retirement Study.

  2014cited by this paper
• Progression of mild Alzheimer’s disease: knowledge and prediction models required for future treatment strategies

  2013cited by this paper
• Modeling Alzheimer's Disease Progression Using Disease Onset Time and Disease Trajectory Concepts Applied to CDR-SOB Scores From ADNI

  2013influential reference

• No citing papers are available for this paper.